The statements below are read from SPECIALITY MEDICINES LIMITED’s filed results, 1 filed quarter and 5 fiscal years on record, standalone basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: H2 FY25-26 · filed May 28, 2026 · audited
This company files half-yearly statements with the exchange — each column is a six-month period; discrete quarterly figures are not published.
| ₹ Cr | H2 FY26Mar 2026Latest | YoYlatest |
|---|---|---|
| Sales | 44.8 | — |
| 36.4 | — | |
| Operating profit | 8.35 | — |
| OPM % | 18.6% | — |
| Other income | 0.70 | — |
| Interest | 0.87 | — |
| Depreciation | 0.08 | — |
| Profit before tax | 8.10 | — |
| Tax % | -1.0% | — |
| Net profit | 8.18 | — |
| EPS (₹) | 12.54 | — |
No results filing with a recorded time yet — reactions appear from the first quarter whose announcement we timestamped (May 2026 onward), on the session the market could trade it.
